Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The contribution of paramagnetic rim and cortical lesions to physical and cognitive disability at multiple sclerosis clinical onset: evaluating the power of MRI and OCT biomarkers.
Miscioscia A, Mainero C, Treaba CA, Silvestri E, Scialpi G, Berardi A, Causin F, Anglani MG, Rinaldi F, Perini P, Puthenparampil M, Bertoldo A, Gallo P. Miscioscia A, et al. J Neurol. 2024 Oct;271(10):6702-6714. doi: 10.1007/s00415-024-12622-8. Epub 2024 Aug 19. J Neurol. 2024. PMID: 39155316
High NEDA and No PIRA in Natalizumab-Treated Patients With Pediatric-Onset Multiple Sclerosis.
Puthenparampil M, Gaggiola M, Ponzano M, Zanotelli G, Miscioscia A, Nosadini M, Di Paola A, Sartori S, Perini P, Rinaldi F, Bovis F, Gallo P. Puthenparampil M, et al. Among authors: miscioscia a. Neurol Neuroimmunol Neuroinflamm. 2024 Sep;11(5):e200303. doi: 10.1212/NXI.0000000000200303. Epub 2024 Aug 14. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39141876 Free PMC article.
Hyper-reflective foci changes in RRMS under natalizumab therapy.
Puthenparampil M, Basili E, Ponzano M, Mauceri VA, Miscioscia A, Pilotto E, Perini P, Rinaldi F, Bovis F, Gallo P. Puthenparampil M, et al. Among authors: miscioscia a. Front Immunol. 2024 Jul 15;15:1421755. doi: 10.3389/fimmu.2024.1421755. eCollection 2024. Front Immunol. 2024. PMID: 39076978 Free PMC article.
Blood-brain barrier damage associates with glia-related cytokines in the cerebrospinal fluid of patients with Multiple Sclerosis.
Puthenparampil M, Marin A, Zanotelli G, Mauceri VA, De Napoli F, Gaggiola M, Miscioscia A, Ponzano M, Bovis F, Perini P, Rinaldi F, Molon B, Gallo P. Puthenparampil M, et al. Among authors: miscioscia a. Mult Scler Relat Disord. 2024 Feb;82:105403. doi: 10.1016/j.msard.2023.105403. Epub 2024 Jan 3. Mult Scler Relat Disord. 2024. PMID: 38184910 Free article.
Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis.
Puthenparampil M, Gaggiola M, Miscioscia A, Mauceri VA, De Napoli F, Zanotelli G, Anglani M, Nosadini M, Sartori S, Perini P, Rinaldi F, Gallo P. Puthenparampil M, et al. Among authors: miscioscia a. Ther Adv Neurol Disord. 2023 Oct 6;16:17562864231177196. doi: 10.1177/17562864231177196. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 37808246 Free PMC article.
23 results